Zürich, Switzerland, February 17, 2010 --(PR.com
)-- Clariness, Europe’s largest provider of innovative services specifically designed for patient recruitment and clinical research, is pleased to announce the opening of a new office in the United States. Clariness, using its internet platform ClinLife (www.clinlife.net), is successfully recruiting in 16 countries in Europe and North America.
Clariness will also open portals in 4 to 6 other countries in 2010, some of which will be located in South America.
With the establishment of an American branch in Princeton, New Jersey, Clariness will have the opportunity to use its innovative and cost-efficient strategies to assist the growing number of clients in the North American region with their patient-recruitment needs. American clients already account for a large portion of the company’s business volume.
“Both North and South America carry out a large number of clinical studies, and as such, are regions with a lot of potential for Clariness,” says Michael Stadler, CEO of Clariness Holding AG. “Last year saw a lot of growth for the company, especially in the US. In order to be both geographically closer and to offer even better services, we have happily made the decision to take this important step. Although the growth rate for patient-recruitment services is higher in Europe, America has by far the largest market. Clinical studies are being conducted globally and in order to better support our clients, Clariness will strengthen its presence in this important region. Expanding our services to North America is another step in our global strategy.”
Clariness offers comprehensive, innovative services to improve patient-recruitment methods and to expedite clinical studies. The company operates ClinLife (www.clinlife.net), the largest international internet platform for patients and clinical studies. ClinLife has already been successfully established in 16 countries and in their respective national languages.
Clariness’ clientele includes many top companies working in the biotech and medical-devices industries, as well as 5 of the largest pharmaceutical companies.